Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy

Radiotherapy and Oncology

Volumn 101, Issue 3, 2011, Pages 410-414

  Zenda, Sadamoto ^a,m   Matsuura, Kazuto ^b   Tachibana, Hiroyuki ^c   Homma, Akihiro ^d   Kirita, Tadaaki ^e   Monden, Nobuya ^f   Iwae, Shigemichi ^g   Ota, Yojiro ^h   Akimoto, Tetsuo ^a,i   Otsuru, Hiroshi ^j   Tahara, Makoto ^a   Kato, Kengo ^k   Asai, Masao ^l  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b Miyagi Cancer Center   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e NARA MEDICAL UNIVERSITY   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^g HYOGO CANCER CENTER   (Japan)

^h SHIZUOKA CANCER CENTER   (Japan)

ⁱ TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^j NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^k TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^l NATIONAL CANCER CENTER HOSPITAL   (Japan)

^m TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

more..

Author keywords

Chemoradiotherapy; Head and neck cancer; Morphine; Supportive care

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; MORPHINE; PARACETAMOL;

ADULT; AGED; ANALGESIA; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHEMORADIOTHERAPY; CONSTIPATION; DERMATITIS; DRUG USE; FEBRILE NEUTROPENIA; FEMALE; HEAD AND NECK CANCER; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MUCOSA INFLAMMATION; MULTICENTER STUDY; NAUSEA; NEUROPATHY; NEUTROPENIA; OUTCOME ASSESSMENT; PAIN; PAIN THRESHOLD; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RESPIRATION DEPRESSION; SIDE EFFECT; SOMNOLENCE; THROMBOCYTOPENIA; URINE RETENTION; WEIGHT REDUCTION; XEROSTOMIA;

ADULT; AGED; ANALGESICS, OPIOID; CHEMORADIOTHERAPY; CISPLATIN; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MORPHINE; PAIN MANAGEMENT;

EID: 81855194319     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.09.016     Document Type: Article

References (23)

1. A.A. Forastiere, H. Goepfert, and M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098
2. D.J. Adelstein, Y. Li, and G.L. Adams An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 2003 92 98
3. J. Bernier, C. Domenge, and M. Ozsahin Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 2004 1945 1952
4. J.S. Cooper, T.F. Pajak, and A.A. Forastiere Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 2004 1937 1944
5. J. Bernier, J.S. Cooper, and T.F. Pajak Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501) Head Neck 27 2005 843 850
6. T.Y. Seiwert, and E.E. Cohen State-of-the-art management of locally advanced head and neck cancer Br J Cancer 92 2005 1341 1348
7. J.B. Vermorken, E. Remenar, and C. van Herpen Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 2007 1695 1704
8. M.R. Posner, D.M. Hershock, and C.R. Blajman Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 2007 1705 1715
9. A.M. Rose-Ped, L.A. Bellm, and J.B. Epstein Complications of radiation therapy for head and neck cancers. The patient's perspective Cancer Nurs 25 2002 461 467 quiz 468-9
10. A. Trotti Toxicity in head and neck cancer: a review of trends and issues Int J Radiat Oncol Biol Phys 47 2000 1 12
11. A. Trotti, L.A. Bellm, and J.B. Epstein Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review Radiother Oncol 66 2003 253 262
12. M. Vera-Llonch, G. Oster, and M. Hagiwara Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma Cancer 106 2006 329 336
13. C. Robertson, A.G. Robertson, and J.H. Hendry Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers Int J Radiat Oncol Biol Phys 40 1998 319 329
14. A. Robertson, D. Charlesworth, and C. Ober Effect of inbreeding avoidance on Hardy-Weinberg expectations: examples of neutral and selected loci Genet Epidemiol 17 1999 165 173
15. P.A. Groome, B. O'Sullivan, and W.J. Mackillop Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: population-based outcomes study supporting need for intensified treatment schedules Int J Radiat Oncol Biol Phys 64 2006 1002 1012
16. H.R. Withers, J.M. Taylor, and B. Maciejewski The hazard of accelerated tumor clonogen repopulation during radiotherapy Acta Oncol 27 1988 131 146
17. N.S. Bese, J. Hendry, and B. Jeremic Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation Int J Radiat Oncol Biol Phys 68 2007 654 661
18. G. Russo, R. Haddad, and M. Posner Radiation treatment breaks and ulcerative mucositis in head and neck cancer Oncologist 13 2008 886 898
19. J.L. Lefebvre, F. Rolland, and M. Tesselaar Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy J Natl Cancer Inst 101 2009 142 152
20. T.M. Mekhail, D.J. Adelstein, and L.A. Rybicki Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube? Cancer 91 2001 1785 1790
21. R.G. Wiggenraad, L. Flierman, and A. Goossens Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary study Clin Otolaryngol 32 2007 384 390
22. H. Lee, C. Havrila, and V. Bravo Effect of oral nutritional supplementation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma Support Care Cancer 16 2008 285 289
23. R.P. Morton, V.L. Crowder, and R. Mawdsley Elective gastrostomy, nutritional status and quality of life in advanced head and neck cancer patients receiving chemoradiotherapy ANZ J Surg 79 2009 713 718